Johnson & Johnson is a U.S.-based healthcare company founded in the late 19th century. It operates in the Healthcare sector, with a focus on pharmaceuticals and medical technology. Its shares are traded on the New York Stock Exchange under the ticker JNJ.

The company’s operations are currently concentrated in two core segments:

• Innovative Medicine: Prescription therapies across areas such as immunology, oncology, neuroscience, cardiovascular and metabolic diseases, and pulmonary conditions.

• MedTech (Medical Devices): Surgical technologies, orthopedics, cardiovascular devices, and vision-related products used in hospitals and clinical settings.

Johnson & Johnson maintains a global presence, operating in dozens of countries and marketing products worldwide. Its business model is research-driven, with consistent investment in R&D to develop new therapies and medical technologies.

The company employs a large global workforce across manufacturing facilities, research centers, and commercial operations. Strategic acquisitions and product innovation have supported its long-term position as one of the largest healthcare companies globally.

History and Development

Johnson & Johnson was founded in the late 1800s as a manufacturer of sterile surgical supplies, becoming a pioneer in standardized medical products.

Throughout the 20th century, the company expanded into pharmaceuticals and medical devices, building a diversified healthcare portfolio and strengthening its international presence.

In recent years, Johnson & Johnson completed the separation of its Consumer Health division into a standalone company, allowing it to focus on pharmaceuticals and medical technology.

The company also played a role in global public health initiatives, including vaccine development and large-scale medical innovation efforts.

Today, Johnson & Johnson remains a leading global healthcare company, centered on scientific research, advanced therapies, and medical technology solutions.

Additional Information

Johnson & Johnson (United States) is listed on the NYSE and has a market capitalization of $653.96 billion, with shareholders equity totaling $84.97 billion.

The company employs approximately 132.250 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Johnson & Johnson reported $97.93 billion in revenue, generating net income of $21.04 billion.

Key financial metrics include a P/E ratio of 31.09, a price-to-book (P/B) ratio of 7.70, and a trailing twelve-month dividend yield of 1.93%.

The company trades under the ticker JNJ.